Always pack your medication in your carry-on bag, never in checked luggage
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women with Polycystic Ovary Syndrome. ClinicalTrials.gov, identifier NCT05702905
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity (TA1152)
Coryell Health doesnt recommend taking GLP-1 medications if you: Are pregnant or breastfeeding Have a personal or family history of medullary thyroid cancer (MTC) Have a diagnosis of multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal conditions Side effects of taking a GLP-1 medication may include: Loss of appetite Nausea and vomiting Diarrhea Dizziness Mildly increased heart rate Pancreatitis Medullary thyroid cancer (MTC) Acute kidney injury If youre unsure whether an existing condition, your personal history or your family history will not mix well with a GLP-1 medication, talk with your Coryell Health primary care provider to determine whether a GLP-1 medication is right for you
When paired with an individualized low-calorie, low-fat diet and a consistent exercise program, GLP-1 therapy can help improve various health markers in overweight adults including high blood pressure, diabetes, or high cholesterol reducing cardiovascular risk and improving metabolic health
Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action
